Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects
W. E. Hardman
,
M. P. Moyer
, I. L. Cameron
Department of Cell Systems & Anatomy
Department of Surgery
Department of Pediatrics
Research output
:
Contribution to journal
›
Article
›
peer-review
76
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Animal Study
16%
Body Weight
16%
Breast Carcinoma
33%
Callosity
33%
Diarrhea
16%
Diet
66%
Growth
16%
Intestine Mucosa
33%
Irinotecan
33%
Malignant Neoplasm
16%
Mucosa
16%
Oil
100%
Side Effect
16%
Supplementation
16%
Therapeutic Procedure
50%
Topoisomerase Inhibitor
16%
Xenograft
50%
Biochemistry, Genetics and Molecular Biology
Animal Experiment
16%
Body Weight
16%
Colon
33%
Dose
16%
Fish Oil
66%
Growth
16%
Intestine Mucosa
33%
Mouse
83%
Mucosa
16%
Small Intestine
33%
Topoisomerase
16%